Glucose metabolism of children with drug-resistant epilepsy, controlled by antiepileptic drugs epilepsy, and first-time nonfebrile seizures was studied through the performance of an oral glucose tolerance test and through insulin, C-peptide, and glycosylated hemoglobin measurements. In the refractory epilepsy group, there were more abnormal oral glucose tolerance test results (62.07%) in comparison to the controlled epilepsy group (25%) and the group of first-time seizures (21.21%). There was a significant difference between the group of refractory epilepsy and every other group concerning the abnormality of the oral glucose tolerance test (P < .05). The mean values of insulin, HbA1c, and C-peptide levels were normal for all groups. The results of the present study suggest that there is a distinction of refractory epilepsies from the drug-controlled ones and the first-induced seizures relating to their metabolic profile, regardless of the type of seizures.
KossoffEHDorwardJLTurnerZPyzikPL. Prospective study of the modified Atkins diet in combination with a ketogenic liquid supplement during the initial month. J Child Neurol. 2011;26:147–151.
2.
KleinPJanousekJBarberAWeissbergerR. Ketogenic diet treatment in adults with refractory epilepsy. Epilepsy Behav. 2010;19:575–579.
3.
HongAMTurnerZHamdyRFKossoffEH. Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia. 2010;51:1403–1407.
4.
CrossJHMcLellanANealEG. The ketogenic diet in childhood epilepsy: where are we now?Arch Dis Child. 2010;95:550–553.
5.
KossoffEH. The ketogenic diet: an appropriate first-line therapy?Expert Rev Neurother. 2010;10:843–845.
6.
FreemanJMKossoffEH. Ketosis and the ketogenic diet, 2010: advances in treating epilepsy and other disorders. Adv Pediatr. 2010;57:315–329.
7.
SmithMPolitzerNMacgarvieD. Efficacy and tolerability of the Modified Atkins Diet in adults with pharmacoresistant epilepsy: A prospective observational study. Epilepsia. 2011;52:775–780.
8.
KossoffEHMcGroganJRBlumlRM. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia. 2006;47:421–424.
9.
EvangeliouASpiliotiMDoulioglouV. Branched chain amino acids as adjunctive therapy to ketogenic diet in epilepsy: pilot study and hypothesis. J Child Neurol. 2009;24:1268–1272.
10.
PfeiferHHThieleEA. Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology. 2005;65:1810–1812.
11.
NishidaMJuhászCSoodS. Cortical glucose metabolism positively correlates with gamma-oscillations in nonlesional focal epilepsy. Neuroimage. 2008;42:1275–1284.
12.
ViannaJBAtallahANPradoGF. The oral glucose tolerance test is frequently abnormal in patients with uncontrolled epilepsy. Epilepsy Behav. 2006;9:140–144.
13.
MirrioneMMSchifferWKSiddiqM. PET imaging of glucose metabolism in a mouse model of temporal lobe epilepsy. Synapse. 2006;59:119–121.
14.
BenedekKJuhászCChuganiDC. Longitudinal changes in cortical glucose hypometabolism in children with intractable epilepsy. J Child Neurol. 2006;21:26–31.
15.
JooEYHongSBHanHJ. Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy. Brain. 2005;128:1802–1810.
16.
KimJHImKCKimJS. Correlation of interictal spike-wave with thalamic glucose metabolism in juvenile myoclonic epilepsy. Neuroreport. 2005;16:1151–1155.
17.
BoughKJ. Energy metabolism as part of the anticonvulsant mechanism of the ketogenic diet. Epilepsia. 2008;49(suppl 8):91–93.
18.
YellenG. Ketone bodies, glycolysis, and KATP channels in the mechanism of the ketogenic diet. Epilepsia. 2008;49(suppl 8):80–82.
19.
BoughKJRhoJM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia. 2007;48:43–58.
20.
SinhaSSiddiquiKA. Definition of intractable epilepsy. Neurosciences (Riyadh). 2011;16:3–9.
21.
GoCSneadOC III. Pharmacologically intractable epilepsy in children: diagnosis and preoperative evaluation. Neurosurg Focus. 2008;25: E2.
22.
World Medical Association General Assembly. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Int Bioethique. 2004;15:124–129.
23.
GabirMMHansonRLDabeleaD. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care. 2000;23:1108–1112.
24.
NicholsonFJPesceAM. Reference ranges for laboratory tests and procedures. In: BehrmanERKliegmanMRJensonBH, eds. Nelson Textbook of Pediatrics. 17th ed. Philadelphia, PA: Saunders; 2004:2396–2408.
25.
JooEYTaeWSHongSB. Regional effects of lamotrigine on cerebral glucose metabolism in idiopathic generalized epilepsy. Arch Neurol. 2006;63:1282–1286.
26.
WongHYChuTSLaiJC. Sodium valproate inhibits glucose transport and exacerbates Glut1-deficiency in vitro. J Cell Biochem. 2005;96:775–785.
27.
SpanakiMVSiegelHKopylevL. The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism. Neurology. 1999;53:1518–1522.
28.
GaillardWDZeffiroTFazilatS. Effect of valproate on cerebral metabolism and blood flow: an 18F-2-deoxyglucose and 15O water positron emission tomography study. Epilepsia. 1996;37:515–521.
29.
LeidermanDBBalishMBromfieldEBTheodoreWH. Effect of valproate on human cerebral glucose metabolism. Epilepsia. 1991;32:417–422.
30.
TheodoreWHBromfieldEOnoratiL. The effect of carbamazepine on cerebral glucose metabolism. Ann Neurol. 1989;25:516–520.
31.
MasuccioFVerrottiAChiavaroliV. Weight gain and insulin resistance in children treated with valproate: the influence of time. J Child Neurol. 2010;25(8):941–947.
32.
VerrottiAMancoRAgostinelliS. The metabolic syndrome in overweight epileptic patients treated with valproic acid. Epilepsia. 2010;51(2):268–273.
33.
RauchenzaunerMHaberlandtEScholl-BürgiS. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children. Epilepsy Res. 2008;80(2-3):142–149.
34.
VerrottiAla TorreRTrottaD. Valproate-induced insulin resistance and obesity in children. Horm Res. 2009;71(3):125–131.
35.
PylvänenVPakarinenAKnipMIsojärviJ. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy. Epilepsy Behav. 2006;8(3):643–648.
36.
SilfenMEManiboAMMcMahonDJ. Comparison of simple measures of insulin sensitivity in young girls with premature adrenarche: the fasting glucose to insulin ratio may be a simple and useful measure. J Clin Endocrinol Metab. 2001;86(6):2863–2868.
37.
KilpatrickESBloomgardenZTZimmetPZ. Is haemoglobin A1c a step forward for diagnosing diabetes?BMJ. 2009;339: b4432.
38.
LuefGAbrahamIHoppichlerF. Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy. Metabolism. 2002;51(10):1274–1278.
39.
NatelsonSMiletichDJSealsCF. Clinical biochemistry of epilepsy. I. Nature of the disease and a review of the chemical findings in epilepsy. Clin Chem. 1979;25(6):889–897.
40.
PierzchalaK. Pharmacoresistant epilepsy—epidemiology and current studies. Neurol Neurochir Pol. 2010;44:285–290.
41.
KossoffEH. Intractable childhood epilepsy: choosing between the treatments. Semin Pediatr Neurol. 2011;18(3):145–149. doi:10.1016/j.spen.2011.06.001.
42.
LöscherW.Animal models of drug-resistant epilepsy. Novartis Found Symp. 2002;243:149–159, 159–166, 180–185.
43.
VeechRLChanceBKashiwayaY. Ketone bodies, potential therapeutic uses. IUBMB Life. 2001;51(4):241–247.
44.
NishidaMAsanoEJuhászC. Cortical glucose metabolism correlates negatively with delta-slowing and spike-frequency in epilepsy associated with tuberous sclerosis. Hum Brain Mapp. 2008;29:1255–1264.
45.
KawaiNKawanishiMTamiyaTNagaoS. Crossed cerebellar glucose hypermetabolism demonstrated using PET in symptomatic epilepsy—case report. Ann Nucl Med. 2005;19:231–234.
46.
MantisJGCentenoNATodorovaMT. Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: role of glucose and ketone bodies. Nutr Metab (Lond). 2004;1:11.
47.
StafstromCEBoughKJ. The ketogenic diet for the treatment of epilepsy: a challenge for nutritional neuroscientists. Nutr Neurosci2003;6:67–79.
48.
HuttenlocherPR. Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res. 1976;10:536–540.
NehligADufourFKlingerM. The ketogenic diet has no effect on the expression of spike-and-wave discharges and nutrient transporters in genetic absence epilepsy rats from Strasbourg. J Neurochem. 2009;109(suppl 1):207–213.
51.
GreeneAETodorovaMTSeyfriedTN. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J Neurochem. 2003;86(3):529–537.
